Stock MYCO MYDECINE INNOVATIONS GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Mydecine Innovations Group Inc. NEO Exchange

Equities

MYCO

CA62849F2008

Biotechnology & Medical Research

End-of-day quote NEO Exchange
Other stock markets
 18:00:00 2023-10-05 EDT 		5-day change 1st Jan Change
0.175 CAD +45.83% Intraday chart for Mydecine Innovations Group Inc. +29.63% -61.11%
07-05 Mydecine Innovations Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
07-02 Mydecine Innovations Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 18.48 4.994 78.73 36.33 7.577 1.037
Enterprise Value (EV) 1 20.21 5.038 79.73 39.33 7.73 6.423
P/E ratio -1.08 x -0.95 x -1.88 x -1.13 x -0.44 x -0.03 x
Yield - - - - - -
Capitalization / Revenue 89 x 18 x 1,346 x 4,848 x - -
EV / Revenue 97.3 x 18.2 x 1,363 x 5,250 x - -
EV / EBITDA -3.66 x -1.57 x -6.68 x -1.76 x -0.48 x -0.68 x
EV / FCF -14.9 x -12.4 x -32 x -2.75 x -1.38 x -1.5 x
FCF Yield -6.72% -8.08% -3.12% -36.4% -72.7% -66.9%
Price to Book 5.5 x 0.5 x 22.1 x 172 x -2.41 x -0.09 x
Nbr of stocks (in thousands) 141 669 3,535 5,219 13,005 52,567
Reference price 2 131.3 7.468 22.27 6.961 0.5826 0.0197
Announcement Date 19-04-30 20-06-02 21-04-30 22-03-31 23-03-31 24-07-02
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.2077 0.2768 0.0585 0.007493 - -
EBITDA 1 -5.52 -3.201 -11.94 -22.31 -16.19 -9.383
EBIT 1 -5.542 -3.265 -12.05 -22.46 -16.28 -9.392
Operating Margin -2,668.81% -1,179.6% -20,598.75% -299,753.13% - -
Earnings before Tax (EBT) 1 -13.36 -3.508 -26.95 -23.58 -17.24 -20.95
Net income 1 -13.36 -3.508 -26.95 -28.9 -11.57 -20.95
Net margin -6,431.45% -1,267.37% -46,074.45% -385,658.6% - -
EPS 2 -122.1 -7.874 -11.85 -6.172 -1.338 -0.6824
Free Cash Flow 1 -1.359 -0.4069 -2.49 -14.3 -5.619 -4.296
FCF margin -654.35% -147.02% -4,256.3% -190,867.89% - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19-04-30 20-06-02 21-04-30 22-03-31 23-03-31 24-07-02
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2
Net sales -0.0138 - -
EBITDA - - -
EBIT - - -
Operating Margin - - -
Earnings before Tax (EBT) -10.88 -5.638 -
Net income -10.88 -5.638 -
Net margin 78,906.38% - -
EPS 1 -2.000 -1.200 -0.3500
Dividend per Share - - -
Announcement Date 22-03-31 22-05-16 22-08-15
1CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 1.73 0.04 1.01 3.01 0.15 5.39
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.3134 x -0.0138 x -0.0842 x -0.1348 x -0.009464 x -0.574 x
Free Cash Flow 1 -1.36 -0.41 -2.49 -14.3 -5.62 -4.3
ROE (net income / shareholders' equity) -579% -52.4% -1,000% -1,250% 1,018% 317%
ROA (Net income/ Total Assets) -86.7% -26.4% -130% -164% -140% -124%
Assets 1 15.41 13.3 20.74 17.61 8.233 16.85
Book Value Per Share 2 23.90 15.00 1.010 0.0400 -0.2400 -0.2300
Cash Flow per Share 2 0.0800 0.0300 0.6200 0.2900 0 0
Capex 1 0.01 - 0.29 0.29 - -
Capex / Sales 4.39% - 500.38% 3,890.32% - -
Announcement Date 19-04-30 20-06-02 21-04-30 22-03-31 23-03-31 24-07-02
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+22.15% 46.56B
LONZA GROUP AG Stock Lonza Group AG
+44.81% 41.67B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.37% 41.16B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+33.84% 32.4B
CELLTRION, INC. Stock Celltrion, Inc.
-6.35% 28.1B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+20.42% 28.18B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+48.83% 14.52B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+45.00% 13.74B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.06% 12.17B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. MYCOF Stock
  4. MYCO Stock
  5. Financials Mydecine Innovations Group Inc.